"The family physicians and providers in the Guthrie Tunkhannock, PA, office are dedicated to providing patients with the best in personalized services."

During the past decade, Guthrie Medical Group PC-Robert Packer Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 55 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 26 clinical trials were completed. i.e. 236.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guthrie Medical Group PC-Robert Packer Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "NRG Oncology" with 6 trials sponsored and "Academic and Community Cancer Research United" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guthrie Medical Group PC-Robert Packer Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Guthrie Medical Group PC-Robert Packer Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials) and "Breast Adenocarcinoma" (5 trials). Many other conditions were trialed in "Guthrie Medical Group PC-Robert Packer Hospital" in a lesser frequency.

Most popular intervention types in "Guthrie Medical Group PC-Robert Packer Hospital" are "Drug" (88 trials), "Other" (86 trials), "Biological" (43 trials), "Procedure" (23 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (32 trials), "Questionnaire Administration" (18 trials), "Paclitaxel" (16 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Guthrie Medical Group PC-Robert Packer Hospital" are 89 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Guthrie Medical Group PC-Robert Packer Hospital". undefined are not yet recruiting, 21 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Guthrie Medical Group PC-Robert Packer Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Guthrie Medical Group PC-Robert Packer Hospital, 2 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Guthrie Medical Group PC-Robert Packer Hospital has several departments that took part in Clinical trials: "Guthrie Cancer Center at Guthrie Clinic Sayre" - 29 trials